Yüklüyor......
Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis
Sofosbuvir (SOF) in combination with ribavirin (RBV) for 12 or 24 weeks is the current standard of care for patients infected with hepatitis C virus (HCV) genotypes 2 and 3, respectively. However, in clinical trials treatment-experienced patients, particularly those with cirrhosis, had suboptimal su...
Kaydedildi:
| Yayımlandı: | Hepatology |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BlackWell Publishing Ltd
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4365682/ https://ncbi.nlm.nih.gov/pubmed/25322962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27567 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|